Full Text
Modelling the Cost-Effectiveness of First-Line Biologics for Rheumatoid Arthritis in England and Wales

Abstract

Authors

C. Righetti M. Lebmeier B. Pennington N.J. Brereton

Back to Volume 16, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×